Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PRODUCTION METHOD FOR T CELLS OR NK CELLS, MEDIUM FOR CULTURING T CELLS OR NK CELLS, METHOD FOR CULTURING T CELLS OR NK CELLS, METHOD FOR MAINTAINING UNDIFFERENTIATED STATE OF UNDIFFERENTIATED T CELLS, AND GROWTH-ACCELERATING AGENT FOR T CELLS OR NK CELLS
Document Type and Number:
WIPO Patent Application WO/2020/116606
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a production method for T cells or NK cells, medium for culturing T cells or NK cells, a method for culturing T cells or NK cells, a method for maintaining the undifferentiated state of undifferentiated T cells, and growth-accelerating agent for T cells or NK cells, which enable efficient growth of T cells or NK cells, and enable maintaining of a state (e.g., undifferentiation) of the cells. The present invention pertains to a production method that is for T cells or NK cells and that comprises culturing T cells or NK cells in a medium containing a bisbenzylisoquinoline alkaloid represented by formula (X-1) or formula (X-2) or a compound obtained by cleaving one ether bond thereof or a pharmaceutically acceptable salt thereof, and the like.

Inventors:
TAKAYANAGI SHINICHIRO (JP)
KUNISATO ATSUSHI (JP)
CHUGANJI SAYAKA (JP)
FUKUMOTO KEN (JP)
NAKAZONO KAZUKI (JP)
KANEKO SHIN (JP)
KAWAI YOHEI (JP)
Application Number:
PCT/JP2019/047808
Publication Date:
June 11, 2020
Filing Date:
December 06, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KIRIN HOLDINGS KK (JP)
UNIV KYOTO (JP)
International Classes:
C12N5/10; C12N15/09
Domestic Patent References:
WO2011030851A12011-03-17
WO2016076415A12016-05-19
WO2017221975A12017-12-28
WO2007069666A12007-06-21
WO2008118820A22008-10-02
WO2009007852A22009-01-15
WO2009032194A12009-03-12
WO2009058413A12009-05-07
WO2009057831A12009-05-07
WO2009075119A12009-06-18
WO2009079007A12009-06-25
WO2009091659A22009-07-23
WO2009101084A12009-08-20
WO2009101407A22009-08-20
WO2009102983A22009-08-20
WO2009114949A12009-09-24
WO2009117439A22009-09-24
WO2009126250A22009-10-15
WO2009126251A22009-10-15
WO2009126655A22009-10-15
WO2009157593A12009-12-30
WO2010009015A22010-01-21
WO2010033906A22010-03-25
WO2010033920A22010-03-25
WO2010042800A12010-04-15
WO2010050626A12010-05-06
WO2010056831A22010-05-20
WO2010068955A22010-06-17
WO2010098419A12010-09-02
WO2010102267A22010-09-10
WO2010111409A22010-09-30
WO2010111422A22010-09-30
WO2010115050A22010-10-07
WO2010124290A22010-10-28
WO2010147395A22010-12-23
WO2010147612A12010-12-23
Foreign References:
JP2018502585A2018-02-01
JP2013536204A2013-09-19
JP2013537171A2013-09-30
JP2015531356A2015-11-02
JP2015509716A2015-04-02
JPS5016732B11975-06-16
JP2018229478A2018-12-06
Other References:
LIU XIN;ZHOU ZHENGREN: "The Effect of Berbamine on the Immunoregulation of BALB/c Mice", JOURNAL OF CHINA MEDICAL UNIVERSITY, vol. 25, no. 3, 30 June 1996 (1996-06-30), CN, pages 229 - 231, XP009528815, ISSN: 0258-4646
ONO MINORU: "Anti-tumor effects of cepharanthin", JAPANESE JOURNAL OF CANCER AND CHEMOTHERAPY, vol. 15, no. 2, 30 November 1987 (1987-11-30), JP, pages 249 - 255, XP009528814, ISSN: 0385-0684
NISHIMURA T ET AL., CELL STEM CELL, vol. 12, no. 1, 2013, pages 114 - 126
TAKAYAMA N ET AL., JOURNAL OF EXPERIMENTAL MEDICINE, vol. 207, no. 13, 2010, pages 2817 - 2830
PORTER ET AL., SCIENCE TRANSLATIONAL MEDICINE, vol. 7, no. 303, 2015, pages 303ra139
NICHOLAS P. RESTIFO, BLOOD, vol. 124, no. 4, 2014, pages 476 - 477
LI Y ET AL., CELL STEM CELL, vol. 23, no. 2, 2018, pages 181 - 192
J. IMMUNOL., vol. 165, no. 1, 2000, pages 139 - 147
EXPERIMENTAL HEMATOL., vol. 29, no. 1, 2001, pages 104 - 113
FRONT. IMMUNOL., vol. 8, no. 458, 2017, pages 1 - 18
YING GU ET AL., BLOOD, vol. 120, no. 24, 2012, pages 4829 - 4839
J ALLERGY CLIN. IMMUNOL., vol. 135, no. 3, 2012, pages 626 - 635
NATURE REVIEWS IMMUNOLOGY, vol. 18, 2018, pages 363 - 373
HUANGFU D ET AL., NAT. BIOTECHNOL., vol. 26, 2008, pages 1269 - 1275
ZHAO Y ET AL., CELL STEM CELL, vol. 3, 2008, pages 132 - 135
EMINLI S ET AL., STEM CELLS, vol. 26, 2008, pages 2467 - 2474
FENG B ET AL., NAT. CELL BIOL., vol. 11, 2009, pages 197 - 203
R. L. JUDSON ET AL., NAT. BIOTECHNOL., vol. 27, 2009, pages 459 - 461
LYSSIOTIS CA ET AL., PROC NATL ACAD SCI USA., vol. 106, 2009, pages 8912 - 8917
KIM JB ET AL., NATURE, vol. 461, 2009, pages 649 - 643
ICHIDA JK ET AL., CELL STEM CELL, vol. 5, 2009, pages 491 - 503
HENG JC ET AL., CELL STEM CELL, vol. 6, 2010, pages 167 - 74
HAN J ET AL., NATURE, vol. 463, 2010, pages 1096 - 100
MALI P ET AL., STEM CELLS, vol. 28, 2010, pages 713 - 720
MAEKAWA M ET AL., NATURE, vol. 474, 2011, pages 225 - 9
CANCER RES., vol. 66, 2006, pages 10995 - 11004
MOL THER., vol. 17, 2009, pages 1453 - 1464
BLOOD, vol. 105, no. 4, 2005, pages 1431 - 1439
JOURNAL OF ELECTROPHORESIS, vol. 60, 2015, pages 7 - 10
LANCET, vol. 365, no. 9471, 2005, pages 1636 - 1641
GATTINONI ET AL., NAT. MED., vol. 15, no. 7, 2009, pages 808 - 813
XIE ET AL., EUR J MED CHEM, vol. 44, no. 8, 2009, pages 3293 - 8
TAN ET AL., INTERNATIONAL JORNAL OF MASS SPETROMETRY, vol. 386, 2015, pages 37 - 41
NAM ET AL., MOL ONCOL, vol. 6, no. 5, 2012, pages 484 - 93
See also references of EP 3892722A4
Attorney, Agent or Firm:
Eikoh Patent Firm, P.C. (JP)
Download PDF: